Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at the ESC Congress 2015

PhilipsRoyal Philips (NYSE: PHG AEX: PHIA) today announced its presence at the ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.

Visitors to the Philips booth (#G200) will experience Philips’ holistic approach to cardiovascular care, featuring its best in class digital tools and capabilities for image guided therapy and ultrasound, intravascular imaging and sensing, treatment, patient monitoring, healthcare IT and advanced software applications driving advancements in predictive and precision medicine in cardiovascular care.

"Holistic cardiovascular care looks beyond the disease to understand what really matters for all involved along the patient journey," said Bert van Meurs, General Manager, Image Guided Therapy for Philips. "Our patient-centric solutions enable novel and effective minimally invasive procedures to diagnose and treat cardiovascular disease. These solutions also support physicians when assessing disease states, help decide and guide the right treatment and confirm whether interventions were successful. In addition, our recent acquisition of Volcano will increase our capabilities to deliver this support to both physicians and patients."

The ESC Congress 2015 is the largest and most influential cardiology event in the world, and will showcase the industry's most promising research and leading innovations. Throughout the event, Philips and their physician partners will participate in several Satellite Symposia and hands-on tutorials on topics including anatomical intelligence and peri-interventional imaging, discussing the latest advances in diagnostic and interventional echo.

Philips' newest ultrasound technology cardiac tool, HeartModelA.I., which brings automated 3D views, robust reproducibility and advanced quantification to cardiac ultrasound imaging, will make its European debut at the Philips Booth (#G200). Philips will also offer demonstrations at the booth of its advanced imaging and ultrasound solutions designed for every step of the patient journey, including:

Delivering More Confident Decision-Making

  • HeartModel - part of a suite of new tools and technologies available on Philips' EPIQ Ultrasound system designed to enhance automation and reproducibility, and helps to address some of the most critical strains on overburdened hospitals and healthcare systems challenged to provide higher quality care at lower costs
  • IntelliSpace Cardiovascular - this workspace gives access to the full range of images and includes a cardiac history timeline to provide a comprehensive overview of the patients' care along the health continuum
  • Minicare 1-20 Acute* - A user-friendly handheld point-of-care blood testing platform that speeds up clinical diagnosis by providing results within minutes

Guiding the Optimal Treatment Path

  • EchoNavigator - Fuses live 3D TEE and X-ray in real time to provide image guidance in the 3D space, supporting physicians in complex structural heart procedures to decide, guide and confirm the optimal treatment path, enabling better patient outcomes and more cost effective care
  • AlluraClarity - simplifies procedures and improves workflow, while delivering excellent image quality at a lower dose
  • Volcano IVUS (intravascular ultrasound) - provides detailed and accurate measurements of the vessel and over a wide range of clinical studies has been shown to help ensure accurate stent expansion and apposition and a reduced need for x-ray imaging
  • Volcano iFR Scout™ - pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions.

* Minicare is still under development and not yet available for sale

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...